Michael Rauch is a top manager, entrepreneur, supervisory board member and investor. From 2019 to 2024, he was CFO and from 2022 also CEO of CompuGroup Medical, Europe’s largest listed healthcare IT company.

He has decades of experience as a CFO in publicly traded companies, private equity-owned companies and family businesses.

Prior to joining CompuGroup Medical, he was CFO at Europe’s largest beauty retailer Douglas and prior to that he held leading CFO and strategy positions at the Dax group Henkel for 16 years, including many years as CFO of Henkel’s Beauty Care division and CFO of Henkel’s largest division, Adhesives Technologies.

Rauch is Chairman of the Supervisory Board of the listed edding AG and is also involved in supporting private equity portfolio companies, family businesses and start-ups with a focus on artificial intelligence, healthcare and fast-moving consumer goods.

He holds an MBA from the Kellogg Graduate School of Management, graduated from the Harvard Advanced Management Program, earned a Master of Laws (with a focus on M&A) and worked abroad for several years (Asia, Northern Europe, UK, USA).